Trial intelligence / Profile preview

Steroid Supplementation After TMJ Arthrocentesis

NCT01770912Phase 2Completed

Sponsor
University of Florida
Start
Mar 2013
Primary completion
Jan 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of triamcinolone hexacetonide in temporomandibular joint disorders (TMD), sponsored by University of Florida. Started Mar 2013; status: completed.

02

Drugs

triamcinolone hexacetonide
03

Conditions

temporomandibular joint disorders (TMD)

Beyond the preview

Go deeper on NCT01770912.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01770912.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call